DPH.L - Dechra Pharmaceuticals plc

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
726,800
681,800
608,000
515,100
481,800
Cost of revenue
314,500
297,000
262,100
223,500
208,700
Gross profit
412,300
384,800
345,900
291,600
273,100
Operating expenses
Research development
49,000
36,100
32,400
28,400
25,100
Selling general and administrative
206,000
178,600
151,300
134,900
125,700
Total operating expenses
255,000
214,700
258,900
232,900
227,600
Operating income or loss
157,300
170,100
87,000
58,700
45,500
Interest expense
23,000
12,200
9,800
11,500
10,500
Income before tax
53,900
77,600
74,000
40,900
27,800
Income tax expense
13,800
19,400
18,500
7,000
-3,100
Income from continuing operations
40,100
58,200
55,500
33,900
30,900
Net income
40,100
58,200
55,500
33,900
30,900
Net income available to common shareholders
40,100
58,200
55,500
33,900
30,900
Basic EPS
-
0.54
0.51
0.33
0.30
Diluted EPS
-
0.53
0.51
0.33
0.30
Basic average shares
-
108,333
108,120
103,133
102,505
Diluted average shares
-
108,987
108,751
103,482
102,762
EBITDA
-
178,900
159,000
122,000
115,100